Proteogenomics drug development workflows are closing the gap between what genomic data predicts and what proteins actually do, but most labs have not yet built the infrastructure to exploit these ...
insights from industryDr. Ruizhi WangFounder and CEOAbselion In this interview, News Medical-Life Sciences speaks with Dr. Ruizhi Wang, Founder and CEO of Abselion, about simplifying the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results